| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 31-Dec-08 | | Total Revenue | 179,371 | 159,557 | 146,642 | 189,746 | | Cost of Revenue | 132,014 | 126,372 | 115,706 | 125,403 | | | Gross Profit | 47,357 | 33,185 | 30,936 | 64,343 | | | Operating Expenses | | Research Development | 22,827 | 26,219 | 22,374 | 24,901 | | Selling General and Administrative | 43,582 | 83,346 | 51,854 | 61,559 | | Non Recurring | 167 | (96,207) | 30,984 | 48,976 | | Others | 1,094 | 1,112 | 1,101 | 1,098 | | | | Total Operating Expenses | 67,670 | 14,470 | 106,313 | 136,534 | | | | Operating Income or Loss | (20,313) | 18,715 | (75,377) | (72,191) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (778) | 1,741 | (7,508) | (11,395) | | Earnings Before Interest And Taxes | (17,121) | 20,456 | (82,885) | (83,586) | | Interest Expense |
-
| 1,339 |
-
|
-
| | Income Before Tax | (17,121) | 19,117 | (82,885) | (83,586) | | Income Tax Expense | (221) | (5,705) | (1,163) | 102,475 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (16,900) | 24,822 | (81,722) | (186,061) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (16,900) | 24,822 | (81,722) | (186,061) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($16,900) | $24,822 | ($81,722) | ($186,061) |
|
0.50% Nasdaq 0.00%
Income Statement
